International Expansion Opportunities Therapixel has recently partnered with global companies like Arterys Inc and Qure, establishing distribution agreements in the US and EU. This indicates potential sales expansion opportunities in international markets for their AI solutions.

Product Portfolio Diversification With the launch of a new version of MammoScreen capable of analyzing 2D and 3D mammograms, Therapixel has diversified its product offerings. Sales representatives can explore cross-selling opportunities within existing customer base to expand revenues.

Increased Funding for Growth Therapixel secured significant funding of $15.8 million in Series B funding, indicating a strong financial position for expansion. This funding can be leveraged by the sales team to drive sales initiatives and capture new market segments.

Executive Leadership Strengthening The recent appointment of Matthieu Leclerc-Chalvet as the chief executive officer brings strong leadership to Therapixel. Sales professionals can leverage this leadership change to establish new business relationships and enhance customer trust.

Competitive Landscape Analysis By evaluating comparable companies like Riverain Technologies, Subtle Medical, and Aidence, sales development representatives can identify market gaps and unique selling points to position Therapixel's AI solutions effectively in a competitive market.